Treatment of Multiple Myeloma: Best Practices from The MD Anderson Cancer Center and Satellites : Episode 11
Multiple Myeloma: An Evolving Treatment Landscape
Closing out their discussion on multiple myeloma, expert panelists share expectations and hopes for the future treatment paradigm.
EP: 1.Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma
EP: 2.Role of Transplant in Newly Diagnosed Multiple Myeloma
EP: 3.Treatment of MM: Value of Tumor Boards in Practice
EP: 4.Treatment Paradigm for Patients With Transplant Ineligible NDMM
EP: 5.Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
EP: 6.Expanding the Treatment Armamentarium in RRMM with Novel Therapies
EP: 7.RRMM: Access to Bispecifics and CAR T-Cell Therapy in Satellite Campuses
EP: 8.Dosing and Sequencing Bispecifics and CAR T-Cell Therapies in R/R MM
EP: 9.Bispecifics in Relapsed/Refractory Multiple Myeloma: Adverse Event Management
EP: 10.Role of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
Now Viewing
EP: 11.Multiple Myeloma: An Evolving Treatment Landscape
EP: 12.Recap: Personalized Therapy Options are on the Horizon for Multiple Myeloma
Recent Videos
Related Content
Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
Ishmael Applewhite, BSN, RN-BC, OCN;Leslie Bennett, MSN, RN;Kathy Mooney, MSN, RN, ACNS-BC, BMTCN®, OCN®
May 6th 2024Podcast
Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
